chr1-248916976-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_170725.3(PGBD2):āc.392T>Cā(p.Ile131Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,612,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_170725.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PGBD2 | NM_170725.3 | c.392T>C | p.Ile131Thr | missense_variant | 3/3 | ENST00000329291.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PGBD2 | ENST00000329291.6 | c.392T>C | p.Ile131Thr | missense_variant | 3/3 | 1 | NM_170725.3 | P1 | |
PGBD2 | ENST00000355360.8 | c.-59-303T>C | intron_variant | 1 | |||||
PGBD2 | ENST00000462488.1 | n.160-303T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000843 AC: 21AN: 249214Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135102
GnomAD4 exome AF: 0.000131 AC: 191AN: 1460518Hom.: 0 Cov.: 31 AF XY: 0.000116 AC XY: 84AN XY: 726640
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 03, 2022 | The c.392T>C (p.I131T) alteration is located in exon 3 (coding exon 2) of the PGBD2 gene. This alteration results from a T to C substitution at nucleotide position 392, causing the isoleucine (I) at amino acid position 131 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at